PS10.1 Development of clinical application guidance for extracellular vesicles and future perspectives including the JSRM-ISEV MOU: Toward international collaboration and industrialization
Prof. Shuji Terai, Japan
08:50 - 09:02
PS10.2 PEGylated-biomimetic nanoparticles for enhanced treatment of idiopathic pulmonary fibrosis
Miss Jisu Son, Korea
09:02 - 09:14
PS10.3 Breakthroughs in 3D printing, functional human islets in an alginate-dECM bioink
Giuseppe Orlando, United States
09:14 - 09:26
PS10.4 Oxygen enabled, high capacity, open encapsulation devices implanted subcutaneously vascularized and reversed diabetes in immunodeficient rats
Amy Kelly, United States
09:26 - 09:38
PS10.5 Targeted lung drug delivery via single-cell particle conjugation for asthma treatment
Miss Ji H Cho, Korea
09:38 - 09:50
PS10.6 Progesterone-induced hybrid epithelial/mesenchymal states enhance regenerative and immunomodulatory properties of amniotic epithelial cells